Research progress on the anticarcinogenic actions and mechanisms of ellagic acid

Hong-Mei Zhang1, Lei Zhao1, Hao Li1

  • 11 Medical Sciences Research Center, 2 Department of Pharmacy, The Second Affiliated Hospital of Southeast University, Nanjing 210003, China ; 3 Nanjing Longyuan Natural Polyphenol Synthesis Institute, Nanjing 210042, China.

Insights

Ellagic acid, a plant-derived compound, shows significant anticancer properties. It inhibits tumor growth and metastasis, offering a promising, low-toxicity alternative for cancer prevention and treatment.

Area of Science:

  • Oncology
  • Natural Products Chemistry

Background:

  • Cancer remains a leading global cause of mortality.
  • Conventional treatments like chemotherapy, surgery, and radiation have limitations in efficacy.
  • Plant-derived compounds are emerging as potential alternatives due to low toxicity and cost.

Purpose of the Study:

  • To review the anticarcinogenic actions and mechanisms of ellagic acid (EA).
  • To explore EA as a potential alternative for cancer prevention and treatment.
  • To discuss future applications of EA in oncology.

Main Methods:

  • Review of recent in vitro and in vivo experimental studies on ellagic acid.
  • Analysis of EA's effects on cancer cell proliferation, apoptosis, and DNA binding.
  • Investigation of EA's impact on inflammation, angiogenesis, and drug resistance.

Main Results:

  • Ellagic acid demonstrates broad anticarcinogenic effects.
  • EA inhibits tumor cell proliferation and induces apoptosis.
  • EA interferes with critical processes for tumor growth and metastasis, including DNA binding, inflammation, angiogenesis, and drug resistance.

Conclusions:

  • Ellagic acid exhibits significant potential as an anticancer agent.
  • EA's multifaceted mechanisms offer a promising avenue for novel cancer therapies.
  • Further research into EA applications could enhance cancer prevention and treatment strategies.